Gene regulatory networks analysis of muscle-invasive bladder cancer subtypes using differential graphical model

BACKGROUND: Recently, erdafitinib (Balversa), the first targeted therapy drug for genetic alteration, was approved to metastatic urothelial carcinoma. Cancer genomics research has been greatly encouraged. Currently, a large number of gene regulatory networks between different states have been constr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yongqing, Chen, Qingyuan, Gong, Meiqin, Zeng, Yuanqi, Gao, Dongrui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638098/
https://www.ncbi.nlm.nih.gov/pubmed/34852762
http://dx.doi.org/10.1186/s12864-021-08113-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638098/
https://www.ncbi.nlm.nih.gov/pubmed/34852762
http://dx.doi.org/10.1186/s12864-021-08113-z

Ejemplares similares